文献速递甲状腺疾病

射频消融与手术治疗单侧多灶性甲状腺微小乳头状癌的五年结局比较

Five-year Outcome Between Radiofrequency Ablation vs Surgery for Unilateral Multifocal Papillary Thyroid Microcarcinoma.
PubMed 文献 · J Clin Endocrinol Metab · 2023-01-01

一项中位随访72.9个月的回顾性研究比较射频消融与手术治疗单侧多灶性甲状腺微小乳头状癌,射频消融组44例、手术组53例,两组疾病进展、淋巴结转移、持续病灶及无复发生存率均无统计学显著差异,射频消融组住院时间、手术时间、估计失血量及费用均更低。

要点

  • 射频消融与手术在单侧多灶性甲状腺微小乳头状癌的6年疾病进展及无复发生存率上无统计学显著差异。
  • 射频消融组住院时间、手术时间、估计失血量及费用均低于手术组。
  • 作者认为射频消融可能是有选择患者中安全有效的手术替代方案。

核心结论

  • 研究显示射频消融与手术对单侧多灶性甲状腺微小乳头状癌的6年结局相当,射频消融可能是有选择患者中安全有效的替代方案。

研究设计与样本

  • 一项在初级保健中心开展的回顾性研究,中位随访72.9个月,共纳入97例单侧多灶性甲状腺微小乳头状癌患者,射频消融组44例、手术组53例。
  • 射频消融组采用双极射频发生器及18号双极射频电极(活性尖端0.9 cm)治疗,手术组行甲状腺腺叶切除加预防性中央颈淋巴结清扫。

主要发现

  • 射频消融组与手术组疾病进展分别为4.5%与3.8%(P≥.999),淋巴结转移分别为2.3%与3.8%(P≥.999),持续病灶分别为2.3%与0%(P=.272),无复发生存率分别为97.7%与96.2%(P=.673),均无统计学显著差异。
  • 射频消融组住院时间0天 vs 手术组8.0(3.0)天(P<.001),手术时间3.5(2.4)分钟 vs 80.0(35.0)分钟(P<.001),估计失血量0 mL vs 20.0(15.0)mL(P<.001),费用1768.3(0.1)美元 vs 2084.4(1173.8)美元(P=.001),射频消融组均低于手术组。
  • 手术组并发症发生率为7.5%,射频消融组无并发症发生(P=.111)。

临床怎么用

  • 作者认为,对于有选择的单侧多灶性甲状腺微小乳头状癌患者,射频消融可能是有选择患者中安全有效的替代方案。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Ultrasound (US)-guided radiofrequency ablation (RFA) has been considered as an alternative to surgery or active surveillance for papillary thyroid microcarcinoma (PTMC). However, little is known about the long-term outcomes of RFA in comparison with surgery for unilateral multifocal PTMC. OBJECTIVE: This work aims to report the comparison between RFA vs surgery for unilateral multifocal PTMC over a more than 5-year follow-up period. METHODS: This was a retrospective study at a primary care center with a median follow-up period of 72.9 months. A total of 97 patients with unilateral multifocal PTMC were treated with RFA (RFA group, n = 44) or surgery (surgery group, n = 53). In the RFA group, patients were treated by a bipolar RFA generator and an 18-gauge bipolar RF electrode with a 0.9-cm active tip. In the surgery group, patients underwent thyroid lobectomy with prophylactic central neck dissection. RESULTS: During the follow-up, no statistically significant differences were found in disease progression (4.5% vs 3.8%; P = ≥.999), lymph node metastasis (2.3% vs 3.8%; P = ≥.999), persistent lesion (2.3% vs 0%; P = .272), and RFS rates (97.7% vs 96.2%; P = .673) in the RFA and surgery groups. Patients undergoing RFA had a shorter hospitalization (0 vs 8.0 [3.0] d; P < .001), shorter procedure time (3.5 [2.4] vs 80.0 [35.0] min; P < .001), lower estimated blood loss (0 vs 20.0 [15.0] mL; P < .001), and lower costs ($1768.3 [0.1] vs $2084.4 [1173.8]; P = .001) than those in the surgery group. The complication rate in the surgery group was 7.5%, whereas none of the RFA-treated patients experienced any complications (P = .111). CONCLUSION: This study revealed 6-year comparable outcomes between RFA and surgery for unilateral multifocal PTMC. RFA may be a safe and effective alternative to surgery in selected patients with unilateral multifocal PTMC.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Yan L, Yang Z, Li Y, et al. Five-year Outcome Between Radiofrequency Ablation vs Surgery for Unilateral Multifocal Papillary Thyroid Microcarcinoma. J Clin Endocrinol Metab. 2023. PMID: 37318878. doi:10.1210/clinem/dgad360

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。